Suchergebnisse - "Cowan, Kyra"

PubPharm (71)

1

Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma

enthalten in: Clinical and translational science | 2024

von Hu, P. | Dai, H. | Bourdage, J. | +10

2

Leveraging Cross-Linking Mass Spectrometry for Modeling Antibody-Antigen Complexes

enthalten in: Journal of proteome research | 2024

von Di Ianni, A. | Di Ianni, A. | Cowan, K. | +2

3

Recommendations and feedback from the European Bioanalysis Forum Workshop : 1 year into ICH M10 - keeping our finger on the pulse

enthalten in: Bioanalysis | 2024

von Timmerman, P. | Barfield, M. | Portabella, E. | +24

4

Leveraging cross-linking mass spectrometry for modeling antibody–antigen complexes

enthalten in: Journal of proteome research | 2024

von Di Iannni, A. | Di Ianni, A. | Cowan, K. | +2

5

Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma

enthalten in: Clinical and Translational Science | 2024

von Hu, P. | Dai, H. | Bourdage, J. | +10

6

Assessing MAPPs assay as a tool to predict the immunogenicity potential of protein therapeutics

enthalten in: Life science alliance | 2024

von Di Ianni, A. | Fraone, T. | Balestra, P. | +3

7

Preclinical risk assessment strategy to mitigate the T-cell dependent immunogenicity of protein biotherapeutics : State of the art, challenges and future perspectives

enthalten in: Journal of pharmaceutical and biomedical analysis | 2023

von Di Ianni, A. | Barbero, L. | Fraone, T. | +2

8

Hybrid liquid chromatography high resolution and accuracy mass spectrometry approach for quantification of antibody-drug conjugates at the intact protein level in biological samples

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2023

von Barbero, L. | Ianni, A. | Molinaro, F. | +2

9

Assay development considerations to improve drug tolerance in direct competitive ligand binding neutralizing antibody assays, pretreatment strategies

enthalten in: Journal of immunological methods | 2023

von Rathi, A. | Rinker, S. | Niu, H. | +3

10

R399E, A Mutated Form of Growth and Differentiation Factor 5, for Disease Modification of Osteoarthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2023

von Gigout, A. | Werkmann, D. | Menges, S. | +8

1
2
3
4
5
6
7
8
Nächster »
[8]